Related Experiment Video
Updated: Mar 28, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Inactivation of the Class II PI3K-C2β Potentiates Insulin Signaling and Sensitivity
Samira Alliouachene1, Benoit Bilanges1, Gaëtan Chicanne2
1UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK.
Abstract:
In contrast to the class I phosphoinositide 3-kinases (PI3Ks), the organismal roles of the kinase activity of the class II PI3Ks are less clear. Here, we report that class II PI3K-C2β kinase-dead mice are viable and healthy but display an unanticipated enhanced insulin sensitivity and glucose tolerance, as well as protection against high-fat-diet-induced liver steatosis. Despite having a broad tissue distribution, systemic PI3K-C2β inhibition selectively enhances insulin signaling only in metabolic tissues. In a primary hepatocyte model, basal PI3P lipid levels are reduced by 60% upon PI3K-C2β inhibition. This results in an expansion of the very early APPL1-positive endosomal compartment and altered insulin receptor trafficking, correlating with an amplification of insulin-induced, class I PI3K-dependent Akt signaling, without impacting MAPK activity. These data reveal PI3K-C2β as a critical regulator of endosomal trafficking, specifically in insulin signaling, and identify PI3K-C2β as a potential drug target for insulin sensitization.
Insights
Class II phosphoinositide 3-kinase-C2β (PI3K-C2β) inhibition enhances insulin sensitivity and glucose tolerance. This finding reveals PI3K-C2β as a potential drug target for metabolic disorders.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Research
Background:
- The specific roles of class II phosphoinositide 3-kinases (PI3Ks) in organismal functions remain largely undefined, unlike class I PI3Ks.
- Understanding PI3K-C2β's function is crucial for metabolic disease research.
Purpose of the Study:
- To investigate the physiological and molecular roles of the kinase activity of PI3K-C2β.
- To explore PI3K-C2β as a potential therapeutic target for metabolic dysregulation.
Main Methods:
- Generation and analysis of PI3K-C2β kinase-dead mice.
- Assessment of insulin sensitivity, glucose tolerance, and liver steatosis.
- Primary hepatocyte culture and analysis of endosomal trafficking and insulin signaling pathways.
Main Results:
- PI3K-C2β kinase-dead mice exhibit enhanced insulin sensitivity, improved glucose tolerance, and protection against diet-induced liver steatosis.
- Systemic inhibition of PI3K-C2β selectively boosts insulin signaling in metabolic tissues.
- PI3K-C2β inhibition reduces basal phosphoinositide 3-phosphate (PI3P) levels, expands early endosomes, and alters insulin receptor trafficking, amplifying class I PI3K-dependent Akt signaling.
Conclusions:
- PI3K-C2β is a key regulator of endosomal trafficking impacting insulin signaling.
- Targeting PI3K-C2β kinase activity offers a promising strategy for enhancing insulin sensitivity and treating metabolic diseases.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Cell Specific Gene Expression
cAMP-dependent Protein Kinase Pathways
Dipeptidyl Peptidase 4 Inhibitors

